The Current Ratio as of December 2025 (TTM) for TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) is 12.81

According to TaiGen Biopharmaceuticals Holdings Limited’s latest financial reports and current stock price. The company's current Current Ratio is 12.81. This represents a change of -24.92% compared to the average of 17.07 of the last 4 quarters.

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Historical Current Ratio (quarterly & annually)

How has 4157.TWO Current Ratio performed in the past?

The mean historical Current Ratio of TaiGen Biopharmaceuticals Holdings Limited over the last ten years is 12.93. The current 12.81 Current Ratio has changed 9.81% with respect to the historical average. Over the past ten years (40 quarters), 4157.TWO's Current Ratio was at its highest in in the September 2021 quarter at 29.10. The Current Ratio was at its lowest in in the March 2017 quarter at 1.85.

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of TaiGen Biopharmaceuticals Holdings Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Average Current Ratio

How has 4157.TWO Current Ratio performed in the past?

The current Current Ratio of TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) Current Ratio vs. Peers

How is 4157.TWO’s Current Ratio compared to its peers?

TaiGen Biopharmaceuticals Holdings Limited’s Current Ratio is less than Pharmosa Biopharm Inc. (14.27), greater than OBI Pharma, Inc. (6.54), greater than Mycenax Biotech Inc. (0.84), less than CHO Pharma, Inc. (21.85), greater than Sinphar Pharmaceutical Co.,Ltd. (2.07), greater than Adimmune Corporation (2.00), less than BioGend Therapeutics Co., Ltd. (21.53), greater than Panion & Bf Biotech Inc. (1.32), greater than Savior Lifetec Corporation (8.88), less than Locus Cell Co., Ltd. (0),

Build a custom stock screener for TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiGen Biopharmaceuticals Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TaiGen Biopharmaceuticals Holdings Limited (4157.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TaiGen Biopharmaceuticals Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.